READISCA is looking for individuals with a clinical or genetic diagnosis of Spinocerebellar Ataxia Type 1 or Type 3 OR individuals with a first-degree relative that has a diagnosis of SCA1 or SCA3. Participants should be in early or pre-symptomatic stages of the disease.

The study will aid in clinical trial readiness for SCA1 and SCA3. This is not a treatment trial. It is a study to get ready for treatment trials that are anticipated within the next 5 years.

Click the Announcement below for full details: